MTOR and cancer: Research has underscored the role of PEPCKs in promoting cancer, particularly PEPCK1, which facilitates colon cancer growth by increasing gluconeogenesis metabolites through phosphoenolpyruvate and pyruvate production, along with mTOR signaling activation [10, 13, 14].